Jazz Pharmaceuticals plc Liquidation Value
JAZZ
Other
Cash & Equivalents
$1.39B
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $1.39B
Total Obligations: -$7.67B
$-6.28B
Per share: $-102.19
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $1.39B
AR: $830.75M
Total Obligations: -$7.67B
$-5.45B
Per share: $-88.67
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $1.39B
AR: $830.75M
Inventory: $416.96M
Total Obligations: -$7.67B
$-5.03B
Per share: $-81.88
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-6.28B | $-102.19 |
| Liquid Liquidation Value | $-5.45B | $-88.67 |
| Operating Liquidation Value | $-5.03B | $-81.88 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $1.39B |
| Accounts Receivable | $830.75M |
| Inventory | $416.96M |
| Current Liabilities | $2.24B |
| Long-term Debt | $5.36B |
| Op. Lease Liability | $65.17M |
| Finance Lease | $3.88M |
| Shares Outstanding | 61.4M |
Explore all 259 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $1.39B | $830.75M | $416.96M | $122.06M | $2.24B | $5.36B | $65.17M | $3.88M |
| 2025-09-30 | $1.33B | $764.36M | $483.11M | $152.23M | $2.27B | $5.36B | $53.43M | N/A |
| 2025-06-30 | $1.19B | $714.00M | $504.99M | $89.37M | $2.07B | $5.36B | $55.11M | N/A |
| 2025-03-31 | $1.86B | $652.99M | $492.78M | $95.93M | $1.22B | $5.34B | $38.78M | N/A |
| 2024-12-31 | $2.41B | $716.76M | $480.44M | $77.87M | $1.04B | $6.08B | $53.27M | $5.01M |
| 2024-09-30 | $2.22B | $723.64M | $539.30M | $85.42M | $1.03B | $6.08B | $71.11M | N/A |
| 2024-06-30 | $1.36B | $698.04M | $542.55M | $97.10M | $1.56B | $5.71B | $67.62M | N/A |
| 2024-03-31 | $1.44B | $707.10M | $577.32M | $80.98M | $1.56B | $5.71B | $56.16M | N/A |
▼ Community Notes